Drug Development Platform Creating Novel Antiviral Therapeutics for Pandemics and Seasonal Influenza with Sam Lee and Jim Martin Cocrystal Pharma TRANSCRIPT
Download PDFMay 8, 2022
Sam Lee, interim Co-CEO and President, and Jim Martin, interim Co-CEO and CFO of Cocrystal Pharma. They're a clinical stage biotech company using their proprietary drug development platform to create novel antiviral therapeutics to treat seasonal influenza and pandemic viral infections like COVID-19.
Jim explains,...
May 8, 2022
Sam Lee, interim Co-CEO and President, and Jim Martin, interim Co-CEO and CFO of Cocrystal Pharma. They're a clinical stage biotech company using their proprietary drug development platform to create novel antiviral therapeutics to treat seasonal influenza and pandemic viral infections like COVID-19.
Jim explains,...
Treating Neurodegenerative and Autoimmune Diseases Through Biology of Human Endogenous Retroviruses with Jesús Martin-Garcia GeNeuro TRANSCRIPT
Download PDFMar 14, 2022
Jesús Martin-Garcia is the CEO of GeNeuro, a Swiss-based clinical stage company focused on novel approaches for treating autoimmune and neurodegenerative diseases. While previously considered junk DNA, human endogenous retroviruses are now being seen in a new light as they represent 8% of human DNA and play a role in...
Mar 14, 2022
Jesús Martin-Garcia is the CEO of GeNeuro, a Swiss-based clinical stage company focused on novel approaches for treating autoimmune and neurodegenerative diseases. While previously considered junk DNA, human endogenous retroviruses are now being seen in a new light as they represent 8% of human DNA and play a role in...
Blood Purification Device Removes Inflammatory Cytokines with Jim Joyce Sigyn Therapeutics TRANSCRIPT
Download PDFJul 27, 2021
Jim Joyce is the Co-Founder, Chairman, and CEO of Sigyn Therapeutics, and we talk about removing inflammatory targets from the bloodstream with advanced blood purification technology.
Jim says, "The next transformative step in the recipe of blood purification is the advancement of devices that can address the sources of...